Lobby Wrap: Pro-psilocybin group enlists By Charlie Pinkerton. Published on Mar 1, 2021 11:43am The West Block of the Parliament buildings (Jolson Lim/iPolitics) Last week, Therapsil, a non-profit that seeks to promote access to psilocybin therapy, saw a board of directors’ member join the Lobby Registry. It’s looking to promote patient-centred psilocybin research in Canada, and help patients and doctors access psilocybin through special regulations. Kitchener-based cybersecurity company Palitronica Inc was the only client organization with more than two registrations. Four other companies had two apiece: Staples Canada ULC, Cape Breton University, and tech company Benchmark Corp. Global Public Affairs was the most active lobbying firm, racking up six registrations this week; CFN Consultants had the second-most with five; Capital Hill Group and Summa Strategies each had four; StrategyCorp Inc. had three registrations; and PAA Public Affairs Advisors, Impact Public Affairs and David Pratt & Associates each had two registrations.